AMN Healthcare Services, Inc. (AMN) — Fair Value Analysis
Base-case fair value (P50): $39.88 · Current price: $34.50 · Verdict: Undervalued
The Verdict on AMN
Based on our latest Monte Carlo simulations, AMN HEALTHCARE INC (AMN) is currently assessed as Fairly Valued. While the stock trades at $34.50, our median fair value (P50) points to $39.88, suggesting a potential +15.6% upside from its current level. This analysis indicates that AMN is neither significantly overvalued nor undervalued at this juncture, reflecting a market price broadly aligned with its intrinsic value as projected across thousands of simulated forward scenarios. The market appears to be pricing AMN close to its fundamental long-term potential, without significant deviation that would suggest a strong buy or sell signal based purely on valuation multiples.
How AMN stacks up against Healthcare
AMN's "Fairly Valued" assessment is strongly supported by its strong quality tier relative to the broader Healthcare sector. This robust operational and financial health provides a solid foundation for its current valuation, suggesting a degree of resilience against sector-specific headwinds and market fluctuations. The company's underlying performance metrics indicate a strong competitive position within its industry, allowing it to command a fair price relative to its peers and the inherent complexities of the Healthcare industry. This strong quality tier underpins the calculated $39.88 median fair value, reinforcing confidence in the simulation's output when compared to the current trading price of $34.50.
What this means for investors
For investors considering AMN at its current price of $34.50, the "Fairly Valued" verdict suggests a balanced risk-reward profile rather than a screaming opportunity or an immediate red flag. The indicated +15.6% to our $39.88 fair value provides a modest buffer, but significant alpha generation might require a catalyst beyond a simple re-rating. While a strong quality tier mitigates some operational risks, investors seeking to understand the full spectrum of potential outcomes—including detailed bear and bull case scenarios and their respective probabilities—can leverage advanced analytical tools. Sign up for FairCurve to see the full bear/bull distribution and track AMN's fair value as new fundamentals are released.
Frequently Asked Questions
Is AMN overvalued or undervalued right now?
Based on our Monte Carlo simulations, AMN is currently fairly valued, with its current price of $34.50 showing a moderate upside to our median fair value (P50) of $39.88.
What is the bear case and bull case for AMN?
The full Monte Carlo distribution, including detailed bear (P10) and bull (P90) targets, along with the probability of achieving upside scenarios, is exclusively available with a free FairCurve account.
How does FairCurve calculate AMN's fair value?
FairCurve calculates AMN's fair value using proprietary Monte Carlo simulations that model thousands of forward financial scenarios, providing a robust estimate of intrinsic value.
How can I track AMN's fair value as it changes?
You can add AMN to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation alerts whenever new financial fundamentals, such as earnings reports, are released.